Diagnostic clarification and treatment support

Serving Kamloops, BC and surrounding areas within the province.

Navigating the challenges of mental health can feel overwhelming, but you don't have to face them alone. Here at Sharedcares, we will support your family physician or nurse practitioner to make a diagnosis and recommend appropriate treatment. Whether you're dealing with anxiety, depression, or other mental health concerns we are here to help.

Discover your path to well-being

Explore the personalized benefits that make your mental health journey more comfortable and convenient.
schedule

Flexible Appointments

Schedule appointments at your convenience and find the best time that fits into your busy life.
lock

Confidential Support

Feel safe and secure knowing your privacy is always respected and protected.
person

Personalized Care

Receive individualized attention tailored to meet your unique mental health needs.

Introducing COMP006: A Phase III multi-center randomised, double-blinded controlled trial to investigate Psilocybin for treatment of Treatment resistant depression (TRD)

The primary aim of the study is to assess the effectiveness and safety of different doses of the investigational product for reducing symptom severity in treatment-resistant depression (TRD). For more info visit: https://clinicaltrials.gov/study/NCT05711940

If you are taking two or more antidepressants and you are still unwell you may qualify as suffering from treatment resistant depression or TRD.This study is looking into a new treatment approach for people with TRD using an investigational product given with psychological support. The study is suitable for people who have been diagnosed with major depression and are currently experiencing a recurrent or single episode of depression but that have not responded to antidepressant treatment.

You may be eligible to participate in this study if you:

· Are 18 years of age or older

· Have been diagnosed with major depression (single or recurrent episodes)

· Are experiencing treatment-resistant depression, defined as failing 2, 3 or 4 pharmacological treatments for your current episode of depression

· Meet additional study criteria.

This is a three-part study which will last up to 62 weeks.

Participants will receive support from study clinicians to help them withdraw off any prohibited medications, including current antidepressants. Participants will be asked to remain off prohibited medications for parts of the study under close medical supervision.

Reimbursement for reasonable, out-of-pocket expenses for travel and other expenses may be available to qualified individuals.

If you are interested in learning more about this study, please contact paige@medicalartsresearch.com

Start Your Journey to Well-being

Schedule your appointment today and take the first step towards a brighter tomorrow.
BOOK NOW